Adocia
(OTC: ADOCY)
|
2:06 PM UTC, 09/01/21 | |||
---|---|---|---|---|
Last: $11.80 | Change: +2.00 | %Change: +20.41% | Volume: 200 |
Open: | $ 11.80 | Volume: | 200 | |
---|---|---|---|---|
High: | $ 11.80 | Yield(%) | n/a | |
Low: | $ 11.80 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 60,082.90 | |
EPS ($) | n/a | Shares Out: | 6,946.00 |
% Price Change (last 4 weeks): | n/a |
---|---|
% Price Change (last 13 weeks): | n/a |
% Price Change (last 26 weeks): | n/a |
% Price Change (last 52 weeks): | n/a |
% Price Change (year to date): | n/a |
Return on Equity (%): | n/a |
---|---|
Return on Assets (%): | n/a |
Return on Invested Capital (%): | n/a |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | n/a |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: Biochaperone Lispro, Combo, M1pram, Glucagon, Gla Glp-1, Glucagon Glp-1 & Cell Therapy. The company was founded by Gérard Soula, Olivier Soula and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.
|
Adocia
115 avenue Lacassagne Lyon AR 69003 Phone: 33.4.72.61.06.10 Fax: 33.4.72.36.39.67 http://www.adocia.com |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | n/a |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | n/a |
Cash Flow ($): | n/a |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | n/a |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | n/a |
---|---|
Current Ratio (x): | n/a |
LT Debt/Equity (x): | n/a |
Total Debt/Equity (x): | n/a |